Noveris Health Sciences Inc.

Noveris Health Sciences Inc.

MYCOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$42.74M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Noveris Health Sciences Inc.Noveris Health Sciences Inc.-6.6--73%--0.2

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$42.74 Million
Enterprise Value$42.30 Million
Earnings per Share$2.37
Beta-5.44
Outstanding Shares58,548,051

Return

Return on Equity-73.25%ROE
Return on Assets165.39%
Return on Invested Capital-96.34%

Valuation & Multiples

P/E Ratio-6.62P/E Ratio
PEG2.4PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.73Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT19.67
Enterprise Value to Net Income25
Total Debt to Enterprise0.01
Debt to Equity-0.17Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 17, 2026
EPS Estimate
-$40.38
Consensus analyst estimate
Revenue Estimate
$239,758
Consensus analyst estimate

Next Earnings Call

Expected Date
May 5, 2027
EPS Estimate
-$19.70
Consensus analyst estimate
Revenue Estimate
$239,758
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Noveris Health Sciences Inc.

3 employees
CEO: Jason Birmingham

Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Rosc...